The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
The bmi-1 gene was first isolated as an oncogene that cooperates with c-myc in the generation of mouse lymphomas. We subsequently identified Bmi-1 as a transcriptional repressor belonging to the mouse Polycomb group. The Polycomb group comprises an important, conserved set of proteins that are required to maintain stable repression of specific target genes, such as homeobox-cluster genes, during development. In mice, the absence of bmi-1 expression results in neurological defects and severe proliferative defects in lymphoid cells, whereas bmi-1 overexpression induces lymphomas. Here we show that bmi-1-deficient primary mouse embryonic fibroblasts are impaired in progression into the S phase of the cell cycle and undergo premature senescence. In these fibroblasts and in bmi-1-deficient lymphocytes, the expression of the tumour suppressors p16 and p19Arf, which are encoded by ink4a, is raised markedly. Conversely, overexpression of bmi-1 allows fibroblast immortalization, downregulates expression of p16 and p19Arf and, in combination with H-ras, leads to neoplastic transformation. Removal of ink4a dramatically reduces the lymphoid and neurological defects seen in bmi-1-deficient mice, indicating that ink4a is a critical in vivo target for Bmi-1. Our results connect transcriptional repression by Polycomb-group proteins with cell-cycle control and senescence.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although specific mechanisms are as yet unknown, the senescence response appears to result in a reorganization of chromatin, at least some aspects of which require pRB activity (Jacobs et al., 1999; Leung et al., 2001; Bandyopadhyay et al., 2002; Itahana et al., 2003; Narita et al., 2003; Zhang et al., 2003, 2005).”
From Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors (2005) · cites this paper as Jacobs et al., 1999
In the citing paper
“Therefore, p16INK4A mediated senescence can be induced via disruption of PRC1/PRC2 complex components such as CBX7, BMI1 or EZH2 followed by decrease in levels of H3K27me3 (Jacobs et al., 1999; Bracken et al., 2003, 2007; Gil et al., 2004).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Jacobs et al., 1999
In the citing paper
“The molecular mechanisms underlying this derepression are not completely understood but have been associated with loss of polycomb group of proteins but independent of p53 (Jacobs et al., 1999; Bracken et al., 2007).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Jacobs et al., 1999
In the citing paper
“Because several studies have established a role for the polycomb group protein Bmi1 in the regulation of p16Ink4a (26–28), we analyzed the levels of Bmi1.”
From Age-Dependent Decline in β-Cell Proliferation Restricts the Capacity of β-Cell Regeneration in Mice (2009) · cites this paper as [27]
In the citing paper
“Overexpression of BMI1 [80], CBX7 [81], or CBX8 [82] results in the direct repression of p16 and senescence delay in human and mouse cells.”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [80]
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Role of the INK4a Locus in Tumor Suppression and Cell Mortality
Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., & DePinho, R. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81079-x · Cited by 1,585
Self-citationTumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566
Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization
Zindy, F., Eischen, C. M., Randle, D. H., Kamijo, T., Cleveland, J. L., Sherr, C. J., & Roussel, M. F. (1998) · Genes & Development · doi:10.1101/gad.12.15.2424 · Cited by 1,245
Alcorta, D. A., Xiong, Y., Phelps, D., Hannon, G., Beach, D., & Barrett, J. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13742 · Cited by 1,008
van der Lugt, N. M., Domen, J., Linders, K., van Roon, M., Robanus-Maandag, E., te Riele, H., van der Valk, M., Deschamps, J., Sofroniew, M., & van Lohuizen, M. (1994) · Genes & Development · doi:10.1101/gad.8.7.757 · Cited by 781
Identification of cooperating oncogenes in Eμ-myc transgenic mice by provirus tagging
van Lohuizen, M., Verbeek, S., Scheljen, B., Wientjens, E., van der Guidon, H., & Berns, A. (1991) · Cell · doi:10.1016/0092-8674(91)90382-9 · Cited by 762
Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer
(1996) · Advances in cancer research · doi:10.1016/s0065-230x(08)60352-8 · Cited by 752
Regulation of p16 CDKN2 Expression and Its Implications for Cell Immortalization and Senescence
Hara, E., Smith, R., Parry, D., Tahara, H., Stone, S., & Peters, G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.859 · Cited by 733
Cited by
Items 401–500 of 1,001
Wang, H., Pan, K., Zhang, H.-K., Weng, D., Zhou, J. M., Li, X. H., Huang, W., Song, H.-F., Chen, M.-S., & Xia, J. (2007) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-007-0316-8 · Cited by 101
“…on the ability of repressing the INK4A-locus, which encodes the tumor suppressor proteins p16Ink4a and p19Arf (mouse homologue of human p14ARF) (Jacobs et al. 1999), and overexpression of Bmi-1 in human mammary epithelial cells will induce telomerase activity and then result in cell…”
InfluentialZhang, H., Ding, J., Jin, J., Guo, J., Liu, J., Karaplis, A. C., Goltzman, D., & Miao, D. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090812 · Cited by 106
“These changes were consistent with the skeletal phenotype observed in the PTHrP(1-84) knockin mouse.”
BackgroundResultInfluentialTakahashi (2010) · International Journal of Oncology · doi:10.3892/ijo_00000764 · Cited by 100
p14ARF homozygous deletion or MDM2 overexpression in Burkitt lymphoma lines carrying wild type p53
Lindström, M. S., Klangby, U., & Wiman, K. G. (2001) · Oncogene · doi:10.1038/sj.onc.1204303 · Cited by 111
“Bmi-1 overexpression has been shown to collaborate with c-myc through averting apoptosis (Jacobs et al., 1999b).”
BackgroundInfluentialTakeda, Y., Mori, T., Imabayashi, H., Kiyono, T., Gojo, S., Miyoshi, S., Hida, N., Ita, M., Segawa, K., Ogawa, S., et al. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.583 · Cited by 101
“bmi-1, a cmyc cooperating oncogene in murine lymphomas, reduces expression of p16INK4a, stimulates cell proliferation [24], and is required for maintenance of self-renewing hematopoietic stem cells [25,26].”
BackgroundFoxM1c Counteracts Oxidative Stress-induced Senescence and Stimulates Bmi-1 Expression
Li, S. K. M., Smith, D. K., Leung, W. Y., Cheung, A. M. S., Lam, E. W. F., Dimri, G. P., & Yao, K.-M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709604200 · Cited by 97
Molecular Regulation of Melanocyte Senescence
Bennett, D. C., & Medrano, E. E. (2002) · Pigment Cell Research · doi:10.1034/j.1600-0749.2002.02036.x · Cited by 95
Niche Regulation of Limbal Epithelial Stem Cells: Relationship between Inflammation and Regeneration
Tseng, S. C. G., He, H., Zhang, S., & Chen, S. (2016) · The Ocular Surface · doi:10.1016/j.jtos.2015.12.002 · Cited by 108
Raaphorst, F. M., van Kemenade, F. J., Fieret, E., Hamer, K. M., Satijn, D. P. E., Otte, A. P., & Meijer, C. J. L. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.1 · Cited by 98
MOZ (KAT6A) is essential for the maintenance of classically defined adult hematopoietic stem cells
Sheikh, B. N., Yang, Y., Schreuder, J., Nilsson, S. K., Bilardi, R., Carotta, S., McRae, H. M., Metcalf, D., Voss, A. K., & Thomas, T. (2016) · Blood · doi:10.1182/blood-2015-10-676072 · Cited by 98
Hematopoietic Stem Cell Development
Cullen, S. M., Mayle, A., Rossi, L., & Goodell, M. A. (2014) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/b978-0-12-416022-4.00002-0 · Cited by 109
Li, X., Yang, Z.-X., Song, W., Zhou, L., Li, Q., Tao, K., Zhou, J., Wang, X., Zheng, Z., You, N., et al. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1992 · Cited by 98
“Bmi-1 also regulates cellular processes including cell cycle progression, apoptosis and senescence as well as immortalisation by repressing the INK4A locus, which encodes two tumour repressor proteins, p16Ink4a and p19Arf (mouse homologue of human p14ARF) (8) and inducing telomerase activity (9).”
BackgroundA novel human homologue of Drosophila polycomblike gene is up-regulated in multiple cancers
Wang, S., Robertson, G. P., & Zhu, J. (2004) · Gene · doi:10.1016/j.gene.2004.09.006 · Cited by 99
Datta, S., Hoenerhoff, M. J., Bommi, P., Sainger, R., Guo, W.-J., Dimri, M., Band, H., Band, V., Green, J. E., & Dimri, G. P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1636 · Cited by 97
Nishida, Y., Maeda, A., Kim, M. J., Cao, L., Kubota, Y., Ishizawa, J., Al-Rawi, A., Kato, Y., Iwama, A., Fujisawa, M., et al. (2017) · Blood Cancer Journal · doi:10.1038/bcj.2017.8 · Cited by 99
Wolter, M., REIFENBERGER, J., Blaschke, B., Ichimura, K., Schmidt, E., Collins, V. P., & Reifenberger, G. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.12.1170 · Cited by 105
“function as a transcriptional repressor of the murine p16INK4a and p19ARF genes (44).”
BackgroundRemembrance of Things Past: Chromatin Remodeling in Plant Development
Goodrich, J., & Tweedie, S. (2002) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.18.040202.114836 · Cited by 120
BMI-1, a promising therapeutic target for human cancer
Wang, M., Li, C., Cui, J., Jiao, M., Wu, T., Li, J., & Nan, K. (2015) · Oncology Letters · doi:10.3892/ol.2015.3361 · Cited by 96
“A number of studies have also demonstrated that BMI-1 is able to promote stem cell self-renewal mainly by interfering with two signaling pathways, p16 Ink4a /Rb and Arf/p53 (20,76,77).”
InfluentialMicroRNA Regulation of Human Breast Cancer Stem Cells
Shimono, Y., Mukohyama, J., Nakamura, S.-I., & Minami, H. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm5010002 · Cited by 101
“Bmi1 was initially identified as an oncogene cooperating with c-myc in a murine model of lymphoma ([114,115], for review [116]).”
Crabtree, J. S., & Miele, L. (2018) · Biomedicines · doi:10.3390/biomedicines6030077 · Cited by 105
Homeotic transformations of the axial skeleton that accompany a targeted deletion of E2f6
Storre, J., Elsässer, H., Fuchs, M., Ullmann, D., Livingston, D. M., & Gaubatz, S. (2002) · EMBO reports · doi:10.1093/embo-reports/kvf141 · Cited by 92
“The proliferation defects of bmi-1–/– cells result, at least in part, from the upregulation of the p16INK4a and p19ARF tumor suppressor genes (Jacobs et al., 1999), suggesting that transcriptional repression of these genes is normally mediated by Bmi-1-containing polycomb complexes.”
BackgroundTranscriptional regulation of cellular senescence
Lanigan, F., Geraghty, J. G., & Bracken, A. P. (2011) · Oncogene · doi:10.1038/onc.2011.34 · Cited by 95
“Indeed, mouse embryonic fibroblasts deficient for the polycomb group protein BMI1 underwent premature cellular senescence, due to the derepression of both the INK4A and ARF genes (Jacobs et al., 1999).”
Histone demethylases in physiology and cancer: a tale of two enzymes, JMJD3 and UTX
Arcipowski, K. M., Martinez, C. A., & Ntziachristos, P. (2016) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2016.03.010 · Cited by 101
Lavigne, M., Francis, N. J., King, I. F. G., & Kingston, R. E. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00006-1 · Cited by 95
Kikuchi, J., Kinoshita, I., Shimizu, Y., Kikuchi, E., Konishi, J. S., Oizumi, S., Kaga, K., Matsuno, Y., Nishimura, M., & Dosaka‐Akita, H. (2010) · Cancer · doi:10.1002/cncr.25128 · Cited by 94
Dutton, A., Woodman, C. B. J., Chukwuma, M. B., Last, J. I. K., Wei, W., Vockerodt, M., Baumforth, K. R. N., Flavell, J. R., Rowe, M., Taylor, A. M. R., et al. (2006) · Blood · doi:10.1182/blood-2006-05-020545 · Cited by 108
Raaphorst, F. M. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00241-2 · Cited by 94
Piunti, A., Rossi, A., Cerutti, A., Albert, M., Jammula, S., Scelfo, A., Cedrone, L., Fragola, G., Olsson, L., Koseki, H., et al. (2014) · Nature Communications · doi:10.1038/ncomms4649 · Cited by 93
Mechanisms of hematopoietic stem cell aging
Ergen, A. V., & Goodell, M. A. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2009.12.010 · Cited by 90
Immortalization of Cementoblast Progenitor Cells With Bmi-1 and TERT
Saito, M., Handa, K., Kiyono, T., Hattori, S., Yokoi, T., Tsubakimoto, T., Harada, H., Noguchi, T., Toyoda, M., Sato, S., et al. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.041006 · Cited by 101
“The polycomb group gene bmi-1 represses the transcription of p16 and p19, and overexpression of Bmi-1 can immortalize mouse embryonic fibroblasts but not human fibroblasts.((16,17)) Therefore, we hypothesized that Bmi-1 and TERT might immortalize BDFCs without affecting their differentiation potential and help to succ…”
BackgroundGene expression profiling of Polycomb, Hox and Meis genes in patients with acute myeloid leukaemia
Grubach, L., Juhl‐Christensen, C., Rethmeier, A., Olesen, L. H., Aggerholm, A., Hokland, P., & Østergaard, M. (2008) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2008.01083.x · Cited by 99
“Given the paradigm that PcG might be involved in the silencing of tumour-suppressor genes (35), it was of particular interest to determine the extent of overexpression of these genes in AML.”
BackgroundLoss of T cell receptor-induced Bmi-1 in the KLRG1 + senescent CD8 + T lymphocyte
Heffner, M., & Fearon, D. T. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706040104 · Cited by 92
Park, H., Kim, C.-H., Jeong, J.-H., Park, M., & Kim, K. S. (2016) · Oncotarget · doi:10.18632/oncotarget.7457 · Cited by 92
Transcriptional gene silencing through epigenetic changes mediated by non-coding RNAs.
Malecová, B., & Morris, K. V. (2010) · PubMed · Cited by 108
Role of Bmi1 in H2A Ubiquitylation and Hox Gene Silencing
Wei, J., Zhai, L., Xu, J., & Wang, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600826200 · Cited by 92
Haga, K., Ohno, S., Yugawa, T., Narisawa‐Saito, M., Fujita, M., Sakamoto, M., Galloway, D. A., & Kiyono, T. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2006.00373.x · Cited by 91
Murao, K., Kubo, Y., Ohtani, N., Hara, E., & Arase, S. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07487.x · Cited by 92
Brunner, M., Thurnher, D., Pammer, J., Geleff, S., Heiduschka, G., Reinisch, C. M., Petzelbauer, P., & Erović, B. M. (2008) · Modern Pathology · doi:10.1038/modpathol.2008.63 · Cited by 103
“57 It has been found to be an important factor of self-renewal and senescence of various stem cells”
BackgroundZhou, Z., Flesken-Nikitin, A., & Nikitin, A. Y. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0768 · Cited by 91
“In hematopoietic and neural stem cells, the Bmi1 protein is critical for stem cell self-renewal (42–44), at least in part, by its regulation through the Ink4a locus (42, 44, 45).”
BackgroundLee, K., Adhikary, G., Balasubramanian, S., Gopalakrishnan, R., McCormick, T. S., Dimri, G. P., Eckert, R. L., & Rorke, E. A. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700949 · Cited by 97
“For example, in some cell types, in the absence of Bmi-1, the levels of p16ink4a and p19arf increase (Jacobs et al., 1999a,b). p16ink4a and p19arf are products of the ink4a-arf locus that function to suppress cell cycle progression. p16ink4a inhibits cell cycle progression by inhibiting cyclin…”
BackgroundInfluentialCardiovascular development: towards biomedical applicability
Torella, D., Ellison, G. M., Karakikes, I., & Nadal‐Ginard, B. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6519-y · Cited by 97
Stommel, J. M., & Wahl, G. M. (2005) · Cell Cycle · doi:10.4161/cc.4.3.1522 · Cited by 87
Yu, T., Chen, X., Zhang, W., Colon, D., Shi, J., Napier, D. L., Rychahou, P. G., Lu, W., Lee, E. Y., Weiss, H. L., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.316349 · Cited by 95
“Bmi1 Is Essential for Colon Cancer Cell Proliferation in Vitro and in Vivo—Because Bmi1 acts as an oncogene that regulates cell proliferation and transformation of several types of cancers (16, 36), we tested whether Bmi1 also regulates proliferation of colon cancer cells.”
BackgroundCirculating Bmi-1 mRNA as a possible prognostic factor for advanced breast cancer patients
Silva, J., García‐Barberán, V., García, J. M., Peña, C., Domínguez, G., Díaz, R., Lorenzo, Y., Hurtado, A., Sánchez, A., & Bonilla, F. (2007) · Breast Cancer Research · doi:10.1186/bcr1760 · Cited by 98
“p19ARF prevents the degradation of p53 by sequestering the p53-inhibitor MDM2, thereby allowing p53mediated cell cycle arrest and apoptosis [23-25].”
BackgroundPark, J. H., & Roeder, R. G. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.02185-05 · Cited by 86
“Several other transcriptional repressors, such as Bmi1, Twist, and pokemon, have been implicated in ARF gene repression and cellular transformation (25, 33, 34), but it remains to be determined whether they play any role in the recruitment of GAS41 to the ARF promoter.”
BackgroundChromatin Architectural Changes during Cellular Senescence and Aging
Sun, L., Yu, R., & Dang, W. (2018) · Genes · doi:10.3390/genes9040211 · Cited by 83
“Polycomb proteins are also involved in the repression of p16INK4a in young individuals [85], and the high expression of p16INK4a in old tissues is partially derived from the decline of Polycomb protein BMI1, which is a potent repressor of p16INK4a [86].”
BackgroundJones, C. J., Kipling, D., Morris, M., Hepburn, P., Skinner, J., Bounacer, A., Wyllie, F. S., Ivan, M., Bartek, J., Wynford-Thomas, D., et al. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.15.5690-5699.2000 · Cited by 89
“Demethylation of promoter sequences clearly plays a part in this (20, 26) and there is long-standing evidence for reduction in DNA methylation during replicative ageing (24); the mechanistic details of such a clock, however, and the role of potential trans-acting factors such as BMI-1 (28) remain obscure.”
BackgroundFu, K., & Hu, Q. (2010) · Molecular pathology library · doi:10.1007/978-1-4419-5698-9_21 · Cited by 89
Smith, K. S., Chanda, S. K., Lingbeek, M., Ross, D. T., Botstein, D., van Lohuizen, M., & Cleary, M. L. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00277-6 · Cited by 93
“…of Bmi-1 in murine tumorigenesis and hematopoietic development are critically dependent on Discussion its ability to repress the INK4A-ARF locus (Jacobs et al., 1999a, 1999b) that encodes tumor suppressor proteins An Essential Oncogenic Pathway Links E2a-Pbx1 with regulatory functions on the Rb…”
BackgroundEpigenetics of Cancer Progression
Vucic, E. A., Brown, C. J., & Lam, W. L. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.2.215 · Cited by 98
Raaphorst, F. M. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi111 · Cited by 95
“Notably, in the absence of Bmi1, p16 and p19 are upregulated and cells become subject to apoptosis/senescence pathways (7, 48).”
BackgroundOxidative Stress‐Mediated Skeletal Muscle Degeneration: Molecules, Mechanisms, and Therapies
Choi, M. H., Ow, J. R., Yang, N.-D., & Taneja, R. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/6842568 · Cited by 99
“Bmi1 is a Polycomb group protein that prevents premature senescence by repressing the INK4A/ARF locus [85].”
BackgroundDeletion of Polycomb Repressive Complex 2 From Mouse Intestine Causes Loss of Stem Cells
Koppens, M. A. J., Bounova, G., Gargiulo, G., Tanger, E., Janssen, H., Cornelissen‐Steijger, P., Blom, M., Song, J., Wessels, L. F. A., & van Lohuizen, M. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.06.020 · Cited by 95
Zheng, S., Chen, P., McMillan, A., Lafuente, A., Lafuente, M. J., Ballesta, A., Trias, M., & Wiencke, J. K. (2000) · Carcinogenesis · doi:10.1093/carcin/21.11.2057 · Cited by 94
Perez-Campo, F. M., Costa, G., Lie-a-Ling, M., Stifani, S., Kouskoff, V., & Lacaud, G. (2014) · Stem Cells · doi:10.1002/stem.1606 · Cited by 80
Chen, S., Han, B., Zhu, Y., Mahabole, M., Huang, J., Beebe, D. C., & Tseng, S. C. G. (2015) · Stem Cells · doi:10.1002/stem.2091 · Cited by 93
Mirzayans, R., Andrais, B., Hansen, G., & Murray, D. (2012) · Biochemistry Research International · doi:10.1155/2012/951574 · Cited by 81
“, BMI-1) [19, 20], histone deacetylases [21, 22], and the transcription regulators E2F1 and c-MYC [21, 23] repress p16INK4A expression.”
BackgroundWilms Tumor Chromatin Profiles Highlight Stem Cell Properties and a Renal Developmental Network
Aiden, A. P., Rivera, M. N., Rheinbay, E., Ku, M., Coffman, E. J., Truong, T. T., Vargas, S. O., Lander, E. S., Haber, D. A., & Bernstein, B. E. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.03.016 · Cited by 85
Cellular Senescence: The Trojan Horse in Chronic Lung Diseases
Hamsanathan, S., Alder, J. K., Sellares, J., Rojas, M., Gurkar, A. U., & Mora, A. L. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2018-0410tr · Cited by 86
Mullighan, C. G., Williams, R. T., Downing, J. R., & Sherr, C. J. (2008) · Genes & Development · doi:10.1101/gad.1673908 · Cited by 96
Context-dependent actions of Polycomb repressors in cancer
Koppens, M. A. J., & van Lohuizen, M. (2015) · Oncogene · doi:10.1038/onc.2015.195 · Cited by 92
Epithelial–mesenchymal transition and cancer stemness: the Twist1–Bmi1 connection
Wu, K.-J., & Yang, M.-H. (2011) · Bioscience Reports · doi:10.1042/bsr20100114 · Cited by 86
Cho, J.-H., Dimri, M., & Dimri, G. P. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.624361 · Cited by 88
“The PcG protein BMI1 is known to regulate cellular senescence via repression of the tumor suppressor p16INK4a (herein referred to as p16) (18, 19).”
BackgroundRattan, S. I. S. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06655.x · Cited by 91
Rare somatic cells from human breast tissue exhibit extensive lineage plasticity
Roy, S., Gascard, P. D., Dumont, N., Zhao, J., Pan, D., Petrie, S. E., Margeta, M., & Tlsty, T. D. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218682110 · Cited by 87
The role of E3 ubiquitin ligases in the development and progression of glioblastoma
Humphreys, L. M., Smith, P., Chen, Z., Fouad, S., & D’Angiolella, V. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-020-00696-6 · Cited by 94
Pascale, R. M., Simile, M. M., Calvisi, D. F., Frau, M., Muroni, M. R., Seddaiu, M. A., Daino, L., Muntoni, M. D., Miglio, M. R. D., Thorgeirsson, S. S., et al. (2005) · Hepatology · doi:10.1002/hep.20962 · Cited by 87
p16INK4a as a Second Effector of the Telomere Damage Pathway
Jacobs, J. J. L., & de Lange, T. (2005) · Cell Cycle · doi:10.4161/cc.4.10.2104 · Cited by 87
Self-citationPolycomb genes and cancer: Time for clinical application?
Crea, F., Paolicchi, E., Márquez, V. E., & Danesi, R. (2011) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2011.10.007 · Cited by 90
Sasaki, M., Ikeda, H., Sato, Y., & Nakanuma, Y. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.051237 · Cited by 90
“A critical target of bmi1 is the INK4a locus, which encodes the p16 and p19 (p14 in humans) tumor suppressor proteins.(14) Overexpression of bmi1 extends the replicative life spans of mouse and human fibroblasts,(14,15) possibly by repressing p16 and p19/p14.”
BackgroundReplicative senescence revisited.
Marcotte, R., & Wang, E. (2002) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/57.7.b257 · Cited by 86
“Indeed, transcription factors such as Bmi-1, which promotes downregulation of both p16INK4a and p19ARF and to a lesser extent p15INK4b, cooperates with activated Ras to promote transformation (54).”
BackgroundBmi1 is essential for leukemic reprogramming of myeloid progenitor cells
Yuan, J., Takeuchi, M., Negishi, M., Oguro, H., Ichikawa, H., & Iwama, A. (2011) · Leukemia · doi:10.1038/leu.2011.85 · Cited by 89
Cudré-Mauroux, C., Occhiodoro, T., König, S., Salmon, P., Bernheim, L., & Trono, D. (2003) · Human Gene Therapy · doi:10.1089/104303403322495034 · Cited by 87
“Prototypes of this category are the SV40 large T antigen (T-Ag), which acts through the binding of Rb and p53 (Ali and DeCaprio, 2001), and Bmi-1, which downregulates the p16 and p19Arf tumor suppressor genes encoded by the ink4a locus (Jacobs et al ., 1999).”
Fuxe, J., Akusjärvi, G., Goike, H. M., Roos, G., Collins, V. P., & Pettersson, R. F. (2000) · PubMed · Cited by 99
Yu, J., Lu, Y., Cui, D., Li, E., Zhu, Y., Zhao, Y., Zhao, F., & Xia, S. (2013) · Oncology Reports · doi:10.3892/or.2013.2897 · Cited by 90
ANRIL Promoter DNA Methylation: A Perinatal Marker for Later Adiposity
Lillycrop, K. A., Murray, R. J. S., Cheong, C. Y., Teh, A. L., Clarke-Harris, R., Barton, S. J., Costello, P. M., Garratt, E. S., Cook, E., Titcombe, P., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.03.037 · Cited by 101
“inhibits CDK4 and CDK6 activity, which regulate the RB-E2F axis and cell cycle progression (Nilsson and Landberg, 2006; Jin et al., 1995; Jacobs et al., 1999; Abella et al., 2005), while p14 also induces cell cycle arrest through its interaction with MDM2, resulting in increased p53 levels that trigger cell cycle arre…”
BackgroundSuppression of the p53- or pRB-mediated G1 checkpoint is required for E2F-induced S-phase entry
Lomazzi, M., Moroni, M. C., Jensen, M. R., Frittoli, E., & Helin, K. (2002) · Nature Genetics · doi:10.1038/ng891 · Cited by 93
Tower, J. (2012) · Wiley Interdisciplinary Reviews Developmental Biology · doi:10.1002/wdev.56 · Cited by 96
BMI1 collaborates with BCR-ABL in leukemic transformation of human CD34+ cells
Rizo, A., Horton, S. J., Olthof, S., Dontje, B., Ausema, A., van Os, R., van den Boom, V., Vellenga, E., de Haan, G., & Schuringa, J. J. (2010) · Blood · doi:10.1182/blood-2010-02-270660 · Cited by 83
Ochiai, H., Takenobu, H., Nakagawa, A., Yamaguchi, Y., Kimura, M., Ohira, M., Okimoto, Y., Fujimura, Y., Koseki, H., Kohno, Y., et al. (2010) · Oncogene · doi:10.1038/onc.2010.22 · Cited by 89
“However, several previous reports have indicated that there could be another important Bmi1 target gene, especially in the nervous system, in addition to p16INK4a/p14ARF (Jacobs et al., 1999; Bruggeman et al., 2007).”
BackgroundContribution of p16INK4a to replicative senescence of human fibroblasts
Brookes, S., Rowe, J., del Arroyo, A. G., BOND, J. A., & Peters, G. G. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.04.035 · Cited by 93
Kranc, K. R., Bamforth, S. D., Bragança, J., Norbury, C., van Lohuizen, M., & Bhattacharya, S. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.21.7658-7666.2003 · Cited by 86
“Genetic evidence indicates that in primary mouse fibroblasts Bmi1 represses p16 and p19 and Mel18 represses p16 (25).”
InfluentialSrivastava, A., Ritesh, K. C., Tsan, Y.-C., Liao, R., Su, F., Cao, X., Hannibal, M., Keegan, C. E., Chinnaiyan, A. M., Martin, D. M., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv499 · Cited by 92
USP22 Acts as an Oncogene by the Activation of BMI-1-Mediated INK4a/ARF Pathway and Akt Pathway
Liu, Y., Jiang, S., Yang, Y., Xu, H., Liu, J.-L., & Wang, X. (2011) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-011-9287-0 · Cited by 85
“to promote the generation of B- and T-cell lymphomas through repression of the Cdkn2a locus [25, 26].”
BackgroundImmortalization and Transformation of Human Cells
C. Hahn, W. (2002) · Molecules and Cells · doi:10.1016/s1016-8478(23)15045-x · Cited by 84
Cho, J.-H., Dimri, M., & Dimri, G. P. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.422931 · Cited by 83
Cellular senescence: a hitchhiker’s guide
Aravinthan, A. (2015) · Human Cell · doi:10.1007/s13577-015-0110-x · Cited by 72
“For example, the absence of Bmi1 [67] and a short exposure of cells to histone deacetylase inhibitors [68] accelerate cellular senescence.”
BackgroundSilva, J., García, J. M., Peña, C., García‐Barberán, V., Domínguez, G., Suárez, D., Camacho, F. I., Espinosa, R., Provencio, M., España, P., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0788 · Cited by 85
PPARγ accelerates cellular senescence by inducing p16INK4α expression in human diploid fibroblasts
Gan, Q., Huang, J., Zhou, R., Niu, J., Zhu, X., Wang, J., Zhang, Z., & Tong, T. (2008) · Journal of Cell Science · doi:10.1242/jcs.026633 · Cited by 82
“It is clear that the p16 promoter is subject to multiple levels of control (Hara et al., 1996; Jacobs et al., 1999); therefore, p16 regulation cannot be explained by a single isolated pathway.”
BackgroundHuang, R., Cheung, N. V., Vider, J., Cheung, I. Y., Gerald, W. L., Tickoo, S. K., Holland, E. C., & Blasberg, R. G. (2011) · The FASEB Journal · doi:10.1096/fj.11-185033 · Cited by 79
“The oncogenetic function of the BMI1 gene is mainly due to its repressive effect on the CDKN2A (INK4A/ARF) tumor suppressor locus (21), which may impact both p16-pRb and p19-p53-p21 pathways of cellular proliferation and senescence (22).”
BackgroundLoss of the human polycomb group protein BMI1 promotes cancer-specific cell death
LIU, L.-M., Andrews, L. G., & Tollefsbol, T. O. (2006) · Oncogene · doi:10.1038/sj.onc.1209454 · Cited by 88
“Furthermore, BMI11 is also implicated to sustain both self-renewal and proliferation of neural stem cells by repressing the function of Ink4a-Arf that can lead to growth arrest and premature senescence (Jacobs et al., 1999a; Bruggeman et al., 2005; Molofsky et al., 2005).”
BackgroundInfluentialThe emerging role of Polycomb repressors in the response to DNA damage
Vissers, J. H. A., van Lohuizen, M., & Citterio, E. (2012) · Journal of Cell Science · doi:10.1242/jcs.107375 · Cited by 75
“An important PcG target is the CDKN2A locus, which encodes the tumour suppressor proteins p16 and p19 (Jacobs et al., 1999).”
BackgroundBMI-1 Is Highly Expressed in M0-Subtype Acute Myeloid Leukemia
Sawa, M., Yamamoto, K., Yokozawa, T., Kiyoi, H., Hishida, A., Kajiguchi, T., Seto, M., Kohno, A., Kitamura, K., Itoh, Y., et al. (2005) · International Journal of Hematology · doi:10.1532/ijh97.05013 · Cited by 81
Bmi‐1 expression predicts prognosis for patients with gastric carcinoma
Liu, J., Song, L., Zhang, X., Guo, B., Feng, Y., Li, X., Liao, W., Zeng, M., & Huang, K. (2007) · Journal of Surgical Oncology · doi:10.1002/jso.20934 · Cited by 83
“As reported [16,17] that overexpression of Bmi-1 allows fibroblast immortalization, downregulates expression of P16 and P19ARF, and in combination with H-ras, leads to neoplastic transformation.”
Lin, S.-P., Lee, Y., Wang, J.-Y., Miller, S. A., Chiou, S., Hung, M., & Hung, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049605 · Cited by 85
“likely requirement for the development of cancer [4,5,6], and”
BackgroundLi, X., Isono, K., Yamada, D., Endo, T. A., Endoh, M., Shinga, J., Mizutani-Koseki, Y., Otte, A. P., Casanova, M., Kitamura, H., et al. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00259-10 · Cited by 80
“Central mediators for cellular senescence, p19 and p16, are encoded by the Cdkn2a locus, which is known as an essential target of PRC1 (30).”
BackgroundTransgenic models of lymphoid neoplasia and development of a pan-hematopoietic vector
Adams, J. M., Harris, A. W., Strasser, A., Ogilvy, S., & Cory, S. (1999) · Oncogene · doi:10.1038/sj.onc.1202997 · Cited by 89
“Probably more relevant for oncogenesis, Bmi-1 promotes immortalization of ®broblasts, apparently because it can down-regulate expression of the p16 locus, including that of its p19 alternative reading frame (ARF), which is normally induced by p53 (Jacobs et al., 1999).”
BackgroundEpigenetic strategies to boost CAR T cell therapy
Akbari, B., Ghahri-Saremi, N., Soltantoyeh, T., Hadjati, J., Ghassemi, S., & Mirzaei, H. R. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.08.003 · Cited by 82
Bone Marrow-Derived Cells: The Influence of Aging and Cellular Senescence
Beausejour, C. M. (2007) · Springer eBooks · doi:10.1007/978-3-540-68976-8_4 · Cited by 89
Reactivation of the inactive X chromosome in development and reprogramming
Ohhata, T., & Wutz, A. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1174-3 · Cited by 84
“Similarly, a mutation of Bmi1 is compatible with female embryo development precluding an essential role in XCI [148].”
Background
Metadata
- Authors
- Jacobs, J. J. L., Kieboom, K., Marino, S., DePinho, R. A., & van Lohuizen, M.
- Affiliations
- The Netherlands Cancer Institute (NL)
- Harvard University (US)
- Venue
- Nature
- Published
- 1999-01
- Volume
- 397
- Issue
- 6715
- Pages
- 164-168
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1481473039
- Cited by
- 1,580
- References
- 30
- Citations by year
- 2026: 12 · 2025: 15 · 2024: 24 · 2023: 29 · 2022: 36 · 2021: 36 · 2020: 42 · 2019: 43 · 2018: 42 · 2017: 53 · 2016: 71 · 2015: 76 · 2014: 76 · 2013: 76 · 2012: 86
- FWCI
- 16.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- BMI1, Polycomb group proteins, p16, p19ARF, cellular senescence, cell proliferation, cell cycle progression, S phase, transcriptional repression, lymphoma, lymphoid cells, neurological deficit, H-Ras, oncogenic transformation, tumor suppressor
- MeSH terms
- Animals, Cell Cycle, Cell Division, Cells, Cultured, Fibroblasts, Gene Expression Regulation, Humans, Nuclear Proteins, Oncogenes, Proteins, Proto-Oncogene Proteins, Repressor Proteins, Genes, Tumor Suppressor, Cellular Senescence, Mice, Knockout, Cyclin-Dependent Kinase Inhibitor p16, Tumor Suppressor Protein p14ARF, Mice, Polycomb Repressive Complex 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.